Opportunities for Improving the Drug Development Process: Results from a Survey of Industry and the FDA

Ernst R. Berndt, Adrian H. B. Gottschalk & Matthew W. Strobeck
Published Date
Copyright 2006
ISBN 0-262-10118-1
DOI 10.1086/ipe.6.25056181
Book: Innovation Policy and the Economy, Volume 6
Book editors: Adam B. Jaffe, Josh Lerner & Scott Stern
PUBLISHER: The MIT Press
Series: Innovation Policy and the Economy
Download Purchase Book

Related

Topics

Health, Education, and Welfare
Health
Public Economics
Other
Law and Economics

Published From Paper

Opportunities for Improving the Drug Development Process: Results from a Survey of Industry and the FDA
- Working Paper
Author(s): Ernst R. Berndt, Adrian H. B. Gottschalk & Matthew W. Strobeck
In the United States, the Food and Drug Administration (FDA) agency is responsible for regulating the safety and...

More from NBER

In addition to working papers, the NBER disseminates affiliates’ latest findings through a range of free periodicals — the NBER Reporter, the NBER Digest, the Bulletin on Retirement and Disability, and the Bulletin on Health — as well as online conference reports, video lectures, and interviews.

Economics of Digitization Figure 1
The Economics of Digitization
  • Article
The NBER Economics of Digitization Project, established in 2010 with support from the Alfred P. Sloan Foundation,...
claudiagoldinpromoimagelecture.png
The 2020 Martin Feldstein Lecture: Journey Across a Century of Women
  • Lecture
Claudia Goldin, the Henry Lee Professor of Economics at Harvard University and a past president of the American...
2020 Methods Lecture Promo Image
Summer Institute 2020 Methods Lectures: Differential Privacy for Economists
  • Lecture
The extent to which individual responses to household surveys are protected from discovery by outside parties depends...